Abstract |
The aim of this study was to evaluate serum midkine (S-MK) concentrations as a prognostic tumour marker in oral squamous cell carcinoma (OSCC). We measured S-MK concentrations in patients with OSCC and healthy volunteers. In addition, we performed real-time quantitative reverse transcription-PCR analysis and immunohistochemistry with fresh tumour samples. To determine whether S-MK concentrations have prognostic value, we performed survival analyses with clinical information by using the log-rank test. Serum midkine concentrations were significantly higher in patients with OSCC than in healthy controls (P<0.001). Serum midkine concentrations were also significantly increased in early-stage OSCC compared with those of healthy individuals (P<0.001). In addition, immunohistochemistry allowed identification of overexpressed MK protein in OSCC tissues. MK mRNA showed higher expression in OSCC samples compared with normal mucosal samples. Patients in high S-MK groups showed a significantly lower 5-year survival rate compared with patients in low S-MK groups (P<0.05). The increased S-MK concentrations in early-stage OSCC were strongly associated with poor survival. Serum midkine concentrations may thus be a useful marker not only for cancer screening but also for predicting prognosis of OSCC patients.
|
Authors | K Ota, H Fujimori, M Ueda, S Shiniriki, M Kudo, H Jono, Y Fukuyoshi, Y Yamamoto, H Sugiuchi, H Iwase, M Shinohara, Y Ando |
Journal | British journal of cancer
(Br J Cancer)
Vol. 99
Issue 4
Pg. 655-62
(Aug 19 2008)
ISSN: 1532-1827 [Electronic] England |
PMID | 18682710
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers, Tumor
- Cytokines
- RNA, Messenger
- Midkine
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Biomarkers, Tumor
(blood, genetics)
- Carcinoma, Squamous Cell
(blood, genetics, pathology)
- Cytokines
(blood)
- Female
- Humans
- Immunoenzyme Techniques
- Male
- Middle Aged
- Midkine
- Mouth Mucosa
(metabolism)
- Mouth Neoplasms
(blood, genetics, pathology)
- Neoplasm Staging
- Prognosis
- RNA, Messenger
(blood, genetics)
- Reverse Transcriptase Polymerase Chain Reaction
- Survival Rate
|